Xiaona Fan

1.1k total citations
43 papers, 855 citations indexed

About

Xiaona Fan is a scholar working on Molecular Biology, Plant Science and Oncology. According to data from OpenAlex, Xiaona Fan has authored 43 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 16 papers in Plant Science and 10 papers in Oncology. Recurrent topics in Xiaona Fan's work include Phytochemistry and Biological Activities (10 papers), Phytochemical compounds biological activities (8 papers) and Traditional and Medicinal Uses of Annonaceae (8 papers). Xiaona Fan is often cited by papers focused on Phytochemistry and Biological Activities (10 papers), Phytochemical compounds biological activities (8 papers) and Traditional and Medicinal Uses of Annonaceae (8 papers). Xiaona Fan collaborates with scholars based in China and United States. Xiaona Fan's co-authors include Jiachen Zi, Jian‐Gong Shi, Yongchun Yang, Sheng Lin, Maoluo Gan, Mingtao Liu, Weixia Song, Jian Liu, Yanling Zhang and Heshu Liu and has published in prestigious journals such as Organic Letters, Advanced Science and Cancer Letters.

In The Last Decade

Xiaona Fan

41 papers receiving 842 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaona Fan China 18 519 294 143 98 97 43 855
Suboj Babykutty India 10 417 0.8× 282 1.0× 161 1.1× 113 1.2× 47 0.5× 14 972
Lokesh Dalasanur Nagaprashantha United States 15 581 1.1× 122 0.4× 164 1.1× 65 0.7× 38 0.4× 23 961
Han-Dong Sun China 19 716 1.4× 263 0.9× 91 0.6× 112 1.1× 57 0.6× 30 960
Xingguo Gong China 19 602 1.2× 140 0.5× 115 0.8× 89 0.9× 29 0.3× 28 1.1k
Fu-Shin Chueh Taiwan 22 576 1.1× 175 0.6× 105 0.7× 89 0.9× 24 0.2× 27 914
Ya Li China 21 696 1.3× 157 0.5× 70 0.5× 79 0.8× 40 0.4× 52 1.0k
Zhaohong Wang China 18 514 1.0× 243 0.8× 109 0.8× 73 0.7× 13 0.1× 34 966
Karen L. Lew United States 7 795 1.5× 270 0.9× 113 0.8× 35 0.4× 51 0.5× 8 1.0k
G D Stoner United States 10 515 1.0× 101 0.3× 170 1.2× 132 1.3× 34 0.4× 14 884
Yuanzhi Lao China 20 647 1.2× 282 1.0× 133 0.9× 167 1.7× 19 0.2× 41 982

Countries citing papers authored by Xiaona Fan

Since Specialization
Citations

This map shows the geographic impact of Xiaona Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaona Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaona Fan more than expected).

Fields of papers citing papers by Xiaona Fan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaona Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaona Fan. The network helps show where Xiaona Fan may publish in the future.

Co-authorship network of co-authors of Xiaona Fan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaona Fan. A scholar is included among the top collaborators of Xiaona Fan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaona Fan. Xiaona Fan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Xiaona, Ziwei Liu, Ying Zhou, et al.. (2025). Restoration of A2M reduces drug resistance and malignancy in paclitaxel-resistant lung cancer cells. The International Journal of Biochemistry & Cell Biology. 185. 106789–106789.
2.
Fan, Xiaona, Hengzhen Li, Jiani Yang, et al.. (2024). TRIM21 Promotes Tumor Growth and Gemcitabine Resistance in Pancreatic Cancer by Inhibiting EPHX1‐Mediated Arachidonic Acid Metabolism. Advanced Science. 12(8). e2413674–e2413674. 8 indexed citations
3.
Li, Hengzhen, Chao Liu, Xiaona Fan, et al.. (2024). VDR promotes pancreatic cancer progression in vivo by activating CCL20-mediated M2 polarization of tumor associated macrophage. Cell Communication and Signaling. 22(1). 224–224. 11 indexed citations
5.
Huang, Junyun, T.F. Guo, Lu Xie, et al.. (2023). The rare-earth yttrium induces cell apoptosis and autophagy in the male reproductive system through ROS-Ca2+-CamkII/Ampk axis. Ecotoxicology and Environmental Safety. 263. 115262–115262. 15 indexed citations
7.
Yan, Rui, Jian Jian Li, Xiaona Fan, et al.. (2022). DCLK1 Suppresses Tumor-Specific Cytotoxic T Lymphocyte Function Through Recruitment of MDSCs via the CXCL1-CXCR2 Axis. Cellular and Molecular Gastroenterology and Hepatology. 15(2). 463–485. 18 indexed citations
8.
Liu, Heshu, Xiaona Fan, Rui Yan, et al.. (2022). A targetable MYBL2-ATAD2 axis governs cell proliferation in ovarian cancer. Cancer Gene Therapy. 30(1). 192–208. 13 indexed citations
9.
Ge, Yang, Heshu Liu, Yuanyuan Zhang, et al.. (2022). Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma. Translational Oncology. 17. 101317–101317. 17 indexed citations
10.
Yan, Rui, Xiaona Fan, Heshu Liu, et al.. (2022). Inhibition of DCLK1 sensitizes resistant lung adenocarcinomas to EGFR-TKI through suppression of Wnt/β-Catenin activity and cancer stemness. Cancer Letters. 531. 83–97. 41 indexed citations
12.
Fan, Xiaona, Dan Wang, Wenjing Zhang, et al.. (2021). Inflammatory Markers Predict Survival in Patients With Advanced Gastric and Colorectal Cancers Receiving Anti–PD-1 Therapy. Frontiers in Cell and Developmental Biology. 9. 638312–638312. 42 indexed citations
13.
Dong, Hua, Xiaofeng Lu, Jiachen Zi, & Xiaona Fan. (2019). Minor Sesquiterpenoid and Steroid Constitutes from Azadirachta indica A. Juss and Their Cytotoxic Activity. Journal of Pharmaceutical and Biomedical Sciences. 9(5). 1 indexed citations
14.
Lin, Pengcheng, Xiaona Fan, Xiaofeng Lu, Gui‐Yang Xia, & Jiachen Zi. (2019). Four limonoids from Bacillus subtilis-fermented neem seeds and their cytotoxic activity. Fitoterapia. 135. 73–78. 7 indexed citations
15.
Lu, Xiaofeng, D. N. Dai, Rongmin Yu, et al.. (2018). [Limonoids from seeds of Azadirachta indica and their cytotoxic activity].. PubMed. 43(3). 537–543. 2 indexed citations
16.
Chen, Jian, Xiaona Fan, Jianhua Zhu, et al.. (2018). Limonoids from seeds of Azadirachta indica A. Juss. and their cytotoxic activity. Acta Pharmaceutica Sinica B. 8(4). 639–644. 31 indexed citations
17.
Li, Hongliang, et al.. (2012). Inhibiting effects of ilexgenin A from Ilex hainanensis Merr. on tumor cell HepG2.. Medicinal plant. 3(11). 91–94. 1 indexed citations
18.
Liu, Mingtao, Sheng Lin, Maoluo Gan, et al.. (2012). Butanolide derivatives from the bark ofMachilus yaoshansis. Journal of Asian Natural Products Research. 14(8). 713–720. 8 indexed citations
19.
Lin, Sheng, Yanling Zhang, Mingtao Liu, et al.. (2012). Methoxylated fatty acids from the bark ofFraxinus sieboldiana. Journal of Asian Natural Products Research. 14(3). 235–243. 6 indexed citations
20.
Cheng, Wei, Chenggen Zhu, Wendong Xu, et al.. (2012). Phenylpropene diglycosides from the bark ofMachilus wangchiana. Journal of Asian Natural Products Research. 14(11). 1046–1053. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026